IDEAS home Printed from https://ideas.repec.org/a/spr/pharmo/v6y2022i4d10.1007_s41669-022-00344-4.html
   My bibliography  Save this article

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis

Author

Listed:
  • Zeki Kocaata

    (Ingress-Health HWM GmbH
    GlaxoSmithKline GmbH & Co. KG)

  • Thomas Wilke

    (IPAM e.V.)

  • Franz Fischer

    (GlaxoSmithKline GmbH & Co. KG)

  • Robert Welte

    (GlaxoSmithKline GmbH & Co. KG)

  • Hermann Einsele

    (Zentrum Innere Medizin)

Abstract

Objective This study aimed to analyze the healthcare resource use (HCRU) and associated costs of multiple myeloma (MM) using German claims data. Methods Anonymized claims data from one of the largest sickness funds in Germany were analyzed. Costs and HCRU were calculated from the perspective of the statutory health insurance. To analyze MM-associated incremental costs in a most recent calendar period for an overall MM population (31 March 2018–31 March 2019), a prevalent cohort of MM patients (continuously insured during 01 January 2010 until 31 March 2019 or death; two or more outpatient and/or one inpatient MM diagnoses [ICD-10: C90.0-] and alive on 31 March 2018) was compared with a control group (not diagnosed with MM) employing propensity-score matching. Additionally, to describe MM-associated HCRU and costs for treated patients per line of treatment (lot), a cohort of newly treated patients was considered (≥ 12 months’ pre-index period without MM treatment). Therapy lines were determined based on observed days of medication supply, treatment switches, and treatment discontinuations. Results Overall, 2523 prevalent MM patients (52.0% female, mean age: 71.3 years) and 1673 newly treated MM patients (50.2% female, mean age: 73.0 years) met the selection criteria and were included in the analyses. After matching, a non-MM counterpart could be identified for 2474 prevalent out of 2523 MM patients. MM-associated incremental HCRU was characterized by an increased number of hospitalizations and a higher number of outpatient specialist visits (per patient-year [ppy] 0.48 additional hospitalizations and 3.80 additional specialist visits; p

Suggested Citation

  • Zeki Kocaata & Thomas Wilke & Franz Fischer & Robert Welte & Hermann Einsele, 2022. "Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis," PharmacoEconomics - Open, Springer, vol. 6(4), pages 619-628, July.
    • Handle: RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00344-4
    DOI: 10.1007/s41669-022-00344-4
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s41669-022-00344-4
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1007/s41669-022-00344-4?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Manuel Neves & Fernanda Trigo & Bergantim Rui & Cristina João & Paulo Lúcio & Neves Mariana & João Mendes & Hugo Pedrosa & Catarina Geraldes, 2021. "Multiple Myeloma in Portugal: Burden of Disease and Cost of Illness," PharmacoEconomics, Springer, vol. 39(5), pages 579-587, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Antoine Bessou & Xavier Colin & Julie De Nascimento & Will Sopwith & Shannon Ferrante & Boris Gorsh & Benjamin Gutierrez & Leah Sansbury & Jenny Willson & Sandhya Sapra & Prani Paka & Feng Wang, 2023. "Assessing the treatment pattern, health care resource utilisation, and economic burden of multiple myeloma in France using the Système National des Données de Santé (SNDS) database: a retrospective co," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(3), pages 321-333, April.
    2. Jacopo Garlasco & Mario Cesare Nurchis & Valerio Bordino & Martina Sapienza & Gerardo Altamura & Gianfranco Damiani & Maria Michela Gianino, 2022. "Cancers: What Are the Costs in Relation to Disability-Adjusted Life Years? A Systematic Review and Meta-Analysis," IJERPH, MDPI, vol. 19(8), pages 1-17, April.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharmo:v:6:y:2022:i:4:d:10.1007_s41669-022-00344-4. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.